This finding supported that the binding efficiencies of SRSF3 and HNRNPH1 to PRMT5 pre-mRNA might influence the level change in PRMT5-ISO5 response to IR treatment in different HCC cells. The gene discussed is PRMT5; the disease is hepatocellular carcinoma.